Numerous demographic and clinical factors also likely contribute to these mortality and survival disparities, including socioeconomic status, healthcare access, the proportion of hormone receptor-negative (estrogen and progesterone receptor-negative, or ER-PR-) breast cancers, and tumor stage. The gene discussed is NR4A1; the disease is breast cancer.